Full Text View
Tabular View
Study Results
Related Studies
An Open-label, Long-term Study of Telmisartan Plus Amlodipine Fixed-dose Combination
This study has been completed.
Study NCT00618774   Information provided by Boehringer Ingelheim Pharmaceuticals
First Received: February 8, 2008   Last Updated: March 2, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hypertension
More general conditions related to this trial
Cardiovascular Diseases
Vascular Diseases
Interventions listed in this trial
telmisartan40/amlodipine5
telmisartan80/amlodipine5
Additional drug interventions recognized in this trial
Amlodipine
Telmisartan
More general drug interventions related to this trial
Angiotensin II Type 1 Receptor Blockers
Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Agents
Calcium Channel Blockers
Cardiovascular Agents
Enzyme Inhibitors
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Protease Inhibitors
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
Boehringer Ingelheim Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services